NewYork-Presbyterian/Queens

Flushing, New York 11365

7 studies enrolling now · 45 studies all time

What they study most

AKI, Anemia, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Bradycardia, Breast Cancer, Catheter-associated Urinary Tract Infection, Cerebral Hemorrhage, Cervical Cancer, Chronic Disease, Communication Disabilities, Coronary Artery Disease

Studies at this site

• Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis — Recruiting now
• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease — Recruiting now
• BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies — Recruiting now
• Clinical Trial of Approaches to Prostate Cancer Surgery — Recruiting now
• CHIME: Comparing Health Interventions for Maternal Equity — Recruiting now
• STICH3C Cardiac Magnetic Resonance Observational Study — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Diabetes Care for Breast Cancer Patients — Completed
• Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy — Running, not enrolling
• ZILRETTA in Subjects With Shoulder Osteoarthritis — Running, not enrolling
• Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 — Running, not enrolling
• Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed — Running, not enrolling
• Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance — Running, not enrolling
• Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
• PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2 — Completed
• Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial — Running, not enrolling
• Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV — Running, not enrolling
• An Evaluation of Patient Reported Outcomes and Clinical Outcomes — Running, not enrolling
• SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study) — Completed
• Conduction System Pacing With INGEVITY+ — Completed
• A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) — Completed
• PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy — Completed
• Study of Cemiplimab in Adults With Cervical Cancer — Completed
• Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) — Completed
• An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI — Completed
• A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer — Stopped early
• Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients — Completed
• Clinical Decision Support to Reduce Catheter Associated Urinary Tract Infections — Completed
• Myocardial Ischemia and Transfusion — Completed
• Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery — Completed
• Absorb IV Randomized Controlled Trial — Completed
• Chronic Hypertension and Pregnancy (CHAP) Project — Completed
• ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH) — Completed
• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage — Completed
• Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria — Stopped early
• Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers — Completed
• Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. — Stopped early
• INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure — Completed
• Proning Early in Awake COVID-19 Hypoxic Respiratory Failure (PREACHR) Study — Completed
• QP ExCELs: MultiPole Pacing (MPP) Sub-Study — Completed
• Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Stopped early
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed